Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 12;11(2):294.
doi: 10.3390/diagnostics11020294.

Next-Generation Molecular Investigations in Lysosomal Diseases: Clinical Integration of a Comprehensive Targeted Panel

Affiliations

Next-Generation Molecular Investigations in Lysosomal Diseases: Clinical Integration of a Comprehensive Targeted Panel

Bénédicte Sudrié-Arnaud et al. Diagnostics (Basel). .

Abstract

Diagnosis of lysosomal disorders (LDs) may be hampered by their clinical heterogeneity, phenotypic overlap, and variable age at onset. Conventional biological diagnostic procedures are based on a series of sequential investigations and require multiple sampling. Early diagnosis may allow for timely treatment and prevent clinical complications. In order to improve LDs diagnosis, we developed a capture-based next generation sequencing (NGS) panel allowing the detection of single nucleotide variants (SNVs), small insertions and deletions, and copy number variants (CNVs) in 51 genes related to LDs. The design of the LD panel covered at least coding regions, promoter region, and flanking intronic sequences for 51 genes. The validation of this panel consisted in testing 21 well-characterized samples and evaluating analytical and diagnostic performance metrics. Bioinformatics pipelines have been validated for SNVs, indels and CNVs. The clinical output of this panel was tested in five novel cases. This capture-based NGS panel provides an average coverage depth of 474× which allows the detection of SNVs and CNVs in one comprehensive assay. All the targeted regions were covered above the minimum required depth of 30×. To illustrate the clinical utility, five novel cases have been sequenced using this panel and the identified variants have been confirmed using Sanger sequencing or quantitative multiplex PCR of short fluorescent fragments (QMPSF). The application of NGS as first-line approach to analyze suspected LD cases may speed up the identification of alterations in LD-associated genes. NGS approaches combined with bioinformatics analyses, are a useful and cost-effective tool for identifying the causative variations in LDs.

Keywords: NGS; inborn errors of metabolism; lysosomal disorders; next generation sequencing.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Overview of the genes included in the different LysoGene sub-panels.

References

    1. Coutinho M.F., Alves S. From rare to common and back again: 60years of lysosomal dysfunction. Mol. Genet. Metab. 2016;117:53–65. doi: 10.1016/j.ymgme.2015.08.008. - DOI - PubMed
    1. de Duve C. The lysosome turns fifty. Nat. Cell Biol. 2005;7:847–849. doi: 10.1038/ncb0905-847. - DOI - PubMed
    1. Parenti G., Andria G., Ballabio A. Lysosomal storage diseases: From pathophysiology to therapy. Annu. Rev. Med. 2015;66:471–486. doi: 10.1146/annurev-med-122313-085916. - DOI - PubMed
    1. Schultz M.L., Tecedor L., Chang M., Davidson B.L. Clarifying lysosomal storage diseases. Trends Neurosci. 2011;34:401–410. doi: 10.1016/j.tins.2011.05.006. - DOI - PMC - PubMed
    1. Tebani A., Afonso C., Marret S., Bekri S. Omics-based strategies in precision medicine: Toward a Paradigm shift in inborn errors of metabolism investigations. Int. J. Mol. Sci. 2016;17:1555. doi: 10.3390/ijms17091555. - DOI - PMC - PubMed

LinkOut - more resources